RHO GTPases in cancer: known facts, open questions, and therapeutic challenges

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Signaling

Background:

• RHO GTPases are traditionally viewed as promoting tumor growth.
• Emerging evidence indicates RHO proteins can also suppress tumors.
• GTPase-independent RHO signaling adds complexity to cancer roles.

Purpose of the Study:

• To review the dual pro- and antitumorigenic functions of RHO proteins.
• To discuss the clinical relevance of RHO pathway mutations in cancer.
• To explore RHO-based anticancer drug development strategies.

Main Methods:

• Literature review of recent studies on RHO GTPases in cancer.
• Analysis of gain- and loss-of-function mutations in RHO pathway genes.
• Discussion of mechanistic insights into RHO signaling in tumors.

Main Results:

• RHO proteins exhibit context-dependent protumorigenic and tumor suppressor activities.
• Mutations in RHO pathway genes are found in cancer patients, challenging established roles.
• GTPase-independent mechanisms contribute to RHO's complex functions in cancer.

Conclusions:

• The dual roles of RHO GTPases necessitate a nuanced understanding in cancer biology.
• Further research is needed to elucidate the clinical significance of RHO mutations.
• Targeting RHO signaling presents both opportunities and challenges for novel cancer therapies.